Hu Jiayu, Shi Wenhua, Xu Jiayue, Liu Shaoxuan, Hu Siya, Fu Wenjing, Wang Jing, Han Fengjuan
Heilongjiang University of Chinese Medicine, Harbin 150040, China.
Fourth Affiliated Hospital of Harbin Medical University, Harbin 150040, China.
Evid Based Complement Alternat Med. 2021 Apr 29;2021:5536849. doi: 10.1155/2021/5536849. eCollection 2021.
Endometrial lesions in patients with polycystic ovary syndrome (PCOS) exhibit complex pathological features, and these patients are at risk of both short-term and long-term complications. Complementary and alternative medicine (CAM), which is gradually becoming more accepted and is believed to be clinically effective, claims to be promising for treating PCOS, and thus its effect on the abnormal endometrium of PCOS patients should be assessed. The present meta-analysis sought to evaluate the efficacy and safety of CAM in treating endometrial lesions in patients with PCOS.
Randomized trials on CAM were identified in four Chinese and seven English-language databases from their establishment to January 2020. The present study included patients diagnosed with PCOS and abnormal endometrial conditions who underwent CAM therapy independently or in combination with traditional western medicine. Data were extracted, and the Cochrane "risk of bias" tool was used to assess methodological quality. Effects were expressed as the relative risk (RR) or mean difference (MD/SMD) with 95% confidence interval (CI) as calculated with Rev Man 5.3.
A total of 13 randomized controlled trials were included, involving 1,297 PCOS patients treated for endometrial abnormalities. Methodological quality was generally unclear or had a low risk of bias. The trials tested four different types of CAM therapies (i.e., traditional Chinese medicine treatment, acupuncture treatment, traditional Chinese medicine in combination with western medicine treatment, and acupuncture in combination with western medicine treatment). CAM treatment could significantly reduce the endometrial thickness in PCOS patients compared to western medicine alone (SMD -0.88, 95% CI [-0.12, -0.57]; = 64%). Compared with clomiphene treatment for the induction of ovulation, CAM treatment showed a clear improvement in endometrial thickness during ovulation (SMD 2.03, 95% CI [1.64, 2.02]; = 48%). Moreover, CAM was more effective than western medicine alone in reducing the endometrial spiral artery pulsatility index. No significant difference was seen between CAM and traditional treatment when these were used to improve traditional Chinese medicine syndrome scores. Acupuncture alone or traditional Chinese medicines (taken orally) in combination with western medicine significantly increased the pregnancy rate of PCOS patients (RR 1.59, 95% CI [1.30, 1.93]; = 51%, < 0.00001), and CAM was more effective than western medicine alone for improving hormone levels. No serious adverse events were reported in 11 of the 13 trials.
CAM may effectively ameliorate the endometrial condition of PCOS patients, and it can regulate the level of hormone secretion to increase the ovulation rate and the pregnancy rate.
多囊卵巢综合征(PCOS)患者的子宫内膜病变具有复杂的病理特征,这些患者存在短期和长期并发症的风险。补充和替代医学(CAM)逐渐被更多人接受,且被认为具有临床疗效,据称对治疗PCOS有前景,因此应评估其对PCOS患者异常子宫内膜的影响。本荟萃分析旨在评估CAM治疗PCOS患者子宫内膜病变的疗效和安全性。
在四个中文数据库和七个英文数据库中检索从建库至2020年1月的关于CAM的随机试验。本研究纳入诊断为PCOS且有异常子宫内膜情况并接受CAM单独治疗或与西医联合治疗的患者。提取数据,并使用Cochrane“偏倚风险”工具评估方法学质量。效应值以相对危险度(RR)或均数差(MD/SMD)表示,并计算95%置信区间(CI),使用Rev Man 5.3软件进行分析。
共纳入13项随机对照试验,涉及1297例接受子宫内膜异常治疗的PCOS患者。方法学质量总体不明确或偏倚风险较低。这些试验测试了四种不同类型的CAM疗法(即中医治疗、针灸治疗、中西医结合治疗以及针药结合治疗)。与单纯西医治疗相比,CAM治疗可显著降低PCOS患者的子宫内膜厚度(SMD -0.88,95%CI[-0.12,-0.57]; = 64%)。与克罗米芬促排卵治疗相比,CAM治疗在排卵期间子宫内膜厚度有明显改善(SMD 2.03,95%CI[1.64,2.02]; = 48%)。此外,在降低子宫内膜螺旋动脉搏动指数方面,CAM比单纯西医治疗更有效。在改善中医证候评分方面,CAM与传统治疗之间未见显著差异。单纯针灸或中药(口服)联合西医治疗可显著提高PCOS患者的妊娠率(RR 1.59,95%CI[1.30,1.93]; = 51%, < 0.00001),且在改善激素水平方面,CAM比单纯西医治疗更有效。13项试验中的11项未报告严重不良事件。
CAM可能有效改善PCOS患者的子宫内膜状况,并能调节激素分泌水平以提高排卵率和妊娠率。